Atherosclerotic disease--what kind of prevention?
de Pádua, F.
Revista Portuguesa de Cardiologia Orgao Oficial da Sociedade Portuguesa de Cardiologia 8(9): 589-591
1989
ISSN/ISBN: 0870-2551 PMID: 2631856 Document Number: 337537
Document emailed within 1 workday
Related Documents
de Pádua, F. 2001: Atherosclerotic disease --Prevention Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 20 Suppl. 5: VYokote, K.; Saito, Y. 2006: Atherosclerotic vascular disease and its prevention in metabolic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl. 9: 30-34
Martino, R.; Benini, D. 1985: The significance of sulodexide in the prevention of obliterative atherosclerotic arterial disease of the lower limbs La Clinica Terapeutica 112(5): 429-437
Stone, J.A.; Cyr, C.; Friesen, M.; Kennedy-Symonds, H.; Stene, R.; Smilovitch, M. 2001: Canadian guidelines for cardiac rehabilitation and atherosclerotic heart disease prevention: a summary Canadian Journal of Cardiology 17 Suppl B: 3b
Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917
Rose, R. 1976: Another kind of prevention Texas Dental Journal 94(1): 7-8
Stiefelhagen, P. 2014: What kind of thrombosis prevention for travel? MMW Fortschritte der Medizin 156(12): 20
Baldini, E.; Prochilo, T. 2004: The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence? I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S79-S80
Okada, M.; Matsuto, T.; Miida, T.; Takahashi, A. 2005: Consultation for the prevention of atherosclerotic diseases Rinsho Byori. Japanese Journal of Clinical Pathology 53(8): 708-711
Bijvoet, O.L. 1987: Paget's disease: a kind of chronic inflammation of the bone Nederlands Tijdschrift Voor Geneeskunde 131(39): 1705-1710
Vivancos-Mora, J.; León-Colombo, T.; Monforte-Dupret, C. 1999: Hypolipemic treatment in the prevention of atherosclerotic plaque complications Revista de Neurologia 29(9): 857-863
Murakami, S.; Kondo, Y.; Tomisawa, K.; Nagate, T. 1999: Prevention of atherosclerotic lesion development in mice by taurine Drugs under Experimental and Clinical Research 25(5): 227-234
Vozovikov, I.N.; Andreeva, E.R.; Kuz'min, S.G. 2004: Photodynamic approaches to elimination and prevention of atherosclerotic changes in the vessels Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 90(5): 569-576
Watanabe, Y.; Yoshida, F.; Matsuo, S.; Mitarai, T.; Hirose, S.; Saito, T.; Oikawa, S.; Shibata, T.; Hara, Y.; Koitabashi, Y. 1989: Lipoprotein glomerulopathy:--a new kind of glomerular disease with peculiar histological findings Nihon Rinsho. Japanese Journal of Clinical Medicine 47(7): 1667-1674
Schmidt, G.; Barthel, P.; Goedel-Meinen, L.; Baedeker, W.; Ulm, K. 1988: Spontaneous variability of ventricular arrhythmias in relation to the kind and extent of underlying heart disease Zeitschrift für Kardiologie 77(8): 523-526
Cortellaro, M.; Cofrancesco, E.; Arbustini, E.; Gabrielli, L.; Tremoli, E. 2000: Systemic cause of unstable atherosclerotic plaques. Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque (ATROCAP) study group Lancet 355(9212): 1362-3; Author Reply 1363-4
Harris, K.A.; Willerth, M.J. 1995: Atherosclerotic disease and stroke Canadian Journal of Surgery. Journal Canadien de Chirurgie 38(5): 400
Dehen, H. 1983: Controlled trial of flurbiprofen (platelet anti-aggregant) in the secondary prevention of atherosclerotic cerebral infarcts Presse Medicale 12(8): 521
Calanca, L.; Alatri, A.; Depairon, M.èl.; Engelberger, R.P.; Mazzolai, L. 2015: Non atherosclerotic arterial disease of lower limbs Revue Medicale Suisse 11(460): 352; 354-356
Futterman, L.G.; Lemberg, L. 2002: Peripheral arterial disease is only the tip of the atherosclerotic "iceberg" American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 11(4): 390-394